Ipsen buys rare disease company Clementia for over $1bn cash plus CVRs
- Specialty Pharmaceuticals
- Includes Earnout
- Full Acquisition
- Payment Includes Cash
- Includes Contract
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.